| 000 | 01783 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250516232202.0 | ||
| 264 | 0 | _c20141124 | |
| 008 | 201411s 0 0 eng d | ||
| 022 | _a1471-2334 | ||
| 024 | 7 |
_a10.1186/1471-2334-14-478 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDymova, Maya A | |
| 245 | 0 | 0 |
_aCharacterization of extensively drug-resistant Mycobacterium tuberculosis isolates circulating in Siberia. _h[electronic resource] |
| 260 |
_bBMC infectious diseases _cSep 2014 |
||
| 300 |
_a478 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAmikacin _xpharmacology |
| 650 | 0 | 4 |
_aAntitubercular Agents _xpharmacology |
| 650 | 0 | 4 |
_aCapreomycin _xpharmacology |
| 650 | 0 | 4 | _aCross-Sectional Studies |
| 650 | 0 | 4 |
_aDrug Resistance, Multiple, Bacterial _xgenetics |
| 650 | 0 | 4 |
_aExtensively Drug-Resistant Tuberculosis _xblood |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGenotype |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIsoniazid _xpharmacology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMicrobial Sensitivity Tests |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aMinisatellite Repeats |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 |
_aMycobacterium tuberculosis _xisolation & purification |
| 650 | 0 | 4 |
_aOfloxacin _xpharmacology |
| 650 | 0 | 4 |
_aRifampin _xpharmacology |
| 650 | 0 | 4 |
_aSiberia _xepidemiology |
| 650 | 0 | 4 |
_aTuberculosis _xgenetics |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aCherednichenko, Andrey G | |
| 700 | 1 | _aAlkhovik, Olga I | |
| 700 | 1 | _aKhrapov, Eugeny A | |
| 700 | 1 | _aPetrenko, Tatjana I | |
| 700 | 1 | _aFilipenko, Maxim L | |
| 773 | 0 |
_tBMC infectious diseases _gvol. 14 _gp. 478 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1186/1471-2334-14-478 _zAvailable from publisher's website |
| 999 |
_c24157117 _d24157117 |
||